Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
NCT03458923
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
Diclofenac Sodium 0.1 ml containing 500µg
DRUG:
Ranibizumab 0.5 mg Solution for Injection
Sponsor
Cairo University